Judge Denies Consumers Cert. In Celexa, Lexapro MDL
A Massachusetts federal judge declined to certify a class of consumers in multidistrict litigation accusing Forest Laboratories of fraudulently promoting Celexa and Lexapro as treatments for pediatric depression, citing individual analyses...To view the full article, register now.
Already a subscriber? Click here to view full article